Literature DB >> 33875881

Immunity after SARS-CoV-2 infections.

Prasanna Jagannathan1,2, Taia T Wang3,4,5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33875881     DOI: 10.1038/s41590-021-00923-3

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  2 in total

1.  Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study.

Authors:  Christian Holm Hansen; Daniela Michlmayr; Sophie Madeleine Gubbels; Kåre Mølbak; Steen Ethelberg
Journal:  Lancet       Date:  2021-03-17       Impact factor: 79.321

2.  Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.

Authors:  Jianmin Zuo; Alexander C Dowell; Hayden Pearce; Kriti Verma; Heather M Long; Jusnara Begum; Felicity Aiano; Zahin Amin-Chowdhury; Katja Hoschler; Tim Brooks; Stephen Taylor; Jacqueline Hewson; Bassam Hallis; Lorrain Stapley; Ray Borrow; Ezra Linley; Shazaad Ahmad; Ben Parker; Alex Horsley; Gayatri Amirthalingam; Kevin Brown; Mary E Ramsay; Shamez Ladhani; Paul Moss
Journal:  Nat Immunol       Date:  2021-03-05       Impact factor: 25.606

  2 in total
  3 in total

1.  Identifying SARS-CoV-2 'memory' NK cells from COVID-19 convalescent donors for adoptive cell therapy.

Authors:  Lara Herrera; Myriam Martin-Inaraja; Silvia Santos; Marta Inglés-Ferrándiz; Aida Azkarate; Miguel A Perez-Vaquero; Miguel A Vesga; Jose L Vicario; Bernat Soria; Carlos Solano; Raquel De Paz; Antonio Marcos; Cristina Ferreras; Antonio Perez-Martinez; Cristina Eguizabal
Journal:  Immunology       Date:  2021-12-02       Impact factor: 7.215

2.  COVIDHunter: COVID-19 Pandemic Wave Prediction and Mitigation via Seasonality Aware Modeling.

Authors:  Mohammed Alser; Jeremie S Kim; Nour Almadhoun Alserr; Stefan W Tell; Onur Mutlu
Journal:  Front Public Health       Date:  2022-06-17

Review 3.  SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants.

Authors:  Daniel Martínez-Flores; Jesús Zepeda-Cervantes; Adolfo Cruz-Reséndiz; Sergio Aguirre-Sampieri; Alicia Sampieri; Luis Vaca
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.